Find clinical trials for Prostate Cancer in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Rochester, MN, USA:
effectiveness of the NanoKnife System when used to ablate localized prostate cancer in intermediate risk subjects with organ-confin ...
Rochester, Minnesota, United States and 1 other location
This study evaluates the efficacy, anti-tumor effect, and immunogenicity of neoadjuvant enoblituzumab given before radical prostatectomy. Pa...
Phase 2
Rochester, Minnesota, United States and 4 other locations
to as AAA617. The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate...
Phase 4
Rochester, Minnesota, United States and 53 other locations
of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...
Phase 2
Rochester, Minnesota, United States and 25 other locations
This study evaluates the diagnostic performance and safety of \[18F\]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate...
Phase 3
Rochester, Minnesota, United States and 5 other locations
of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...
Rochester, Minnesota, United States and 32 other locations
The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
Phase 3
Rochester, Minnesota, United States and 18 other locations
This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate ca...
Phase 2
Rochester, Minnesota, United States and 17 other locations
The purpose of this study is to establish the maximum tolerable dose of niraparib when combined with prostate stereotactic body radiotherapy...
Phase 1, Phase 2
Rochester, Minnesota, United States and 5 other locations
vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to ...
Phase 3
Rochester, Minnesota, United States and 63 other locations
Clinical trials
Research sites
Resources
Legal